Put companies on watchlist
thyssenkrupp nucera AG & Co. KGaA
ISIN: DE000NCA0001
WKN: NCA000
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

thyssenkrupp nucera AG & Co. KGaA · ISIN: DE000NCA0001 · EQS - Company News (54 News)
Country: Germany · Primary market: Germany · EQS NID: 1640615
24 May 2023 10:23AM

thyssenkrupp nucera Partners with OxyChem to Install Next Generation eBiTAC v7 Electrolyzers



EQS-Media / 24.05.2023 / 10:23 CET/CEST

thyssenkrupp nucera Partners with OxyChem to Install Next Generation eBiTAC v7 Electrolyzers

  • thyssenkrupp nucera next generation eBiTAC v7 electrolyzers will be installed at OxyChem's Battleground large-scale chlor-alkali electrolysis plant in LaPorte, Texas.
  • OxyChem's Battleground plant, the largest chlorine and caustic soda producer, is converting to membrane technology. 

La Porte/Dortmund, May 24, 2023 – thyssenkrupp nucera is partnering with OxyChem to install the latest generation eBiTAC v7 electrolyzers to support the conversion of its Battleground plant in LaPorte, Texas, from the diaphragm to membrane chlor-alkali technology.

"The fact that OxyChem has contracted us for the important retrofit of its large chlor-alkali plant makes us very pleased because it demonstrates the great trust and partnership, we have built with OxyChem through our chlor-alkali technology and service," says Dr. Werner Ponikwar, CEO and Chairman of the Executive Board of thyssenkrupp nucera AG & Co. KGaA.

thyssenkrupp nucera offers world-class technologies for highly efficient electrolysis plants and supports the conversion of OxyChem's Battleground plant diaphragm cells. Production and delivery will take approximately three years, and thyssenkrupp nucera will expand its manufacturing facilities to accommodate this significant supply agreement.

"OxyChem has had a long-standing partnership with thyssenkrupp nucera that supports our production of essential commodity chemicals helping elevate the quality of life across the globe”, says Wade Alleman, OxyChem Executive Vice President of Technology, Business Development & Support. "This multi-year project will modernize our chlor-alkali manufacturing process and increase our production capacity.”

In this project, thyssenkrupp nucera was involved in the early stages of project development and supplied the basic design for the core of the chlor-alkali facility. The transformation of the chlor-alkali plant into membrane technology is scheduled to begin in 2023 and is expected to be finished by 2026.

 

Media inquiries:  

 thyssenkrupp nucera
Rita Syre 
Senior Media Relations Manager
Phone: +49 231 22972 2522
Mobile: + 49 174 161 86 24 
Mail: rita.syre@thyssenkrupp-nucera.com
 

 

Investor inquiries:

thyssenkrupp nucera
Dr. Hendrik Finger
Head of Investor Relations
Phone: +49 231 229 724 347
Mail: hendrik.finger@thyssenkrupp-nucera.com
 

 

About thyssenkrupp nucera:  

thyssenkrupp nucera offers world-leading technologies for highly efficient electrolysis plants. The company has extensive expertise in the design, procurement, and construction of electrochemical plants. Its track record includes more than 600 successfully installed projects with a total capacity of more than 10 gigawatts. thyssenkrupp nucera's chlor-alkali electrolysis plants allow significant savings in construction costs and offer fast, simple, and cost-effective assembly.

www.thyssenkrupp-nucera.com

 

 



End of Media Release


Issuer: thyssenkrupp nucera AG & Co. KGaA
Key word(s): Enterprise

24.05.2023 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: thyssenkrupp nucera AG & Co. KGaA
Voßkuhle 38
44141 Dortmund
Germany
E-mail: info@thyssenkrupp.com
Internet: www.thyssenkrupp-nucera.com
ISIN: DE000NCA0001
WKN: NCA000
Listed: Regulated Market in Frankfurt
EQS News ID: 1640615

IPO geplant / Intended to be listed;
 
End of News EQS Media

1640615  24.05.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1640615&application_name=news&site_id=boersengefluester_html
Visual performance / price development - thyssenkrupp nucera AG & Co. KGaA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.